We serve Chemical Name:4-Ethenylbenzeneacetic acid ethyl ester CAS:53162-12-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:4-Ethenylbenzeneacetic acid ethyl ester
CAS.NO:53162-12-2
Synonyms:4-ethenylbenzeneacetate ethyl;Ethyl 4-ethenylbenzeneacetate
Molecular Formula:C12H14O2
Molecular Weight:190.24
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:273.0±9.0 ºC (760 Torr)
Density:1.030±0.06 g/cm3 (20 ºC 760 Torr)
Index of Refraction:
PSA:
Exact Mass:
LogP:
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 4-ethenylbenzeneacetate ethyl chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Ethyl 4-ethenylbenzeneacetate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Ethyl 4-ethenylbenzeneacetate Use and application,Ethyl 4-ethenylbenzeneacetate technical grade,usp/ep/jp grade.
Related News: “In the past few years, the pharmaceutical industry has seen rapid growth driven by the growth of small molecules’ innovations, complex APIs and the increasing need to optimize available resources. 6-(4-chloro-phenyl)-2-(2-hydroxy-ethylamino)-4-phenyl-nicotinonitrile manufacturers Conducted by Innovent in China, the CIBI321A101 trial is a Phase 1a open-label, multi-center study of the safety, tolerability and primary efficacy of IBI321 in patients with advanced solid tumors. Phase 1a of the study will evaluate dosing of IBI321 in a variety of solid tumors (ClinicalTrials.gov, NCT04911894). 5(6)-n-butyl-2-mercaptobenzimidazole suppliers High viral load in the respiratory tract correlates with severe illness and mortality in patients with COVID-19,” said Zhiqiang An, PhD, director of UTHealth Texas Therapeutics Institute, professor and Robert A. Welch Distinguished University Chair in Chemistry at McGovern Medical School at UTHealth, and faculty member at MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences and one of the corresponding authors on the study.
“Respiratory mucosal antibodies are key to clearing SARS-CoV-2 infection and reducing viral transmission and IgM antibodies are nature’s first line of defense against pathogens such as viruses. [Pt2(μ-S)2(PPh3Me2)4] vendor & factory.
“Respiratory mucosal antibodies are key to clearing SARS-CoV-2 infection and reducing viral transmission and IgM antibodies are nature’s first line of defense against pathogens such as viruses. [Pt2(μ-S)2(PPh3Me2)4] vendor & factory.
